| Primary Tumor (T) | |
| Regional Lymph Nodes (N) | |
| Distant Metastasis (M) | |
This view displays the TNM formula. Please select appropriate value from the list for T/N/M variables. The result will be displayed, based on your selection of variables.
Assignment of AJCC TNM
AJCC data elements required for staging are identified with an asterisk (*).
*Stage classification based on time frame and criteria(see Rules for Classification)
The same classification should be used throughout the assignment of TNM and stage group.
| T Category | FIGO Stage | T Criteria |
|---|---|---|
| TX | N/A | Primary tumor cannot be assessed |
| T0 | N/A | No evidence of primary tumor |
| T1 | I | Carcinoma is strictly confined to the cervix (extension to the corpus should be disregarded) |
| T1a | IA | Invasive carcinoma that can be diagnosed only by microscopy with maximum depth of invasion 5 mm |
| T1a1 | IA1 | Measured stromal invasion 3 mm in depth |
| T1a2 | IA2 | Measured stromal invasion 3 mm and 5 mm in depth |
| T1b | IB | Invasive carcinoma with measured deepest invasion 5 mm (greater than stage IA); lesion limited to the cervix uteri with size measured by maximum tumor diameter The involvement of vascular/lymphatic spaces should not change the staging. The lateral extent of the lesion is no longer considered. |
| T1b1 | IB1 | Invasive carcinoma 5 mm depth of stromal invasion and 2 cm in greatest dimension |
| T1b2 | IB2 | Invasive carcinoma 2 cm and 4 cm in greatest dimension |
| T1b3 | IB3 | Invasive carcinoma 4 cm in greatest dimension |
| T2 | II | Cervical carcinoma invades beyond the cervix, but has not extended onto the lower third of the vagina or to the pelvic wall |
| T2a | IIA | Involvement limited to the upper two-thirds of the vagina without parametrial invasion |
| T2a1 | IIA1 | Invasive carcinoma 4 cm in greatest dimension |
| T2a2 | IIA2 | Invasive carcinoma 4 cm in greatest dimension |
| T2b | IIB | With parametrial invasion but not up to the pelvic wall |
| T3 | III | Carcinoma involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or non-functioning kidney The pelvic wall is defined as the muscle, fascia, neurovascular structures, and skeletal portions of the bony pelvis. Cases with no cancer-free space between the tumor and pelvic wall by rectal examination are FIGO III. |
| T3a | IIIA | Carcinoma involves lower third of the vagina, with no extension to the pelvic wall |
| T3b | IIIB | Extension to the pelvic wall and/or hydronephrosis or non-functioning kidney (unless known to be due to another cause) |
| T4 | IVA | Carcinoma has involved (biopsy proven) the mucosa of the bladder or rectum, or has spread to adjacent organs. (Bullous edema, as such, does not permit a case to be allotted to stage IVA) |
| cT Category | FIGO Stage | cT Criteria |
|---|---|---|
| cTX | N/A | Primary tumor cannot be assessed |
| cT0 | N/A | No evidence of primary tumor |
| cT1 | I | Carcinoma is strictly confined to the cervix (extension to the corpus should be disregarded) |
| cT1a | IA | Invasive carcinoma that can be diagnosed only by microscopy with maximum depth of invasion 5 mm |
| cT1a1 | IA1 | Measured stromal invasion 3 mm in depth |
| cT1a2 | IA2 | Measured stromal invasion 3 mm and 5 mm in depth |
| cT1b | IB | Invasive carcinoma with measured deepest invasion 5 mm (greater than stage IA); lesion limited to the cervix uteri with size measured by maximum tumor diameter The involvement of vascular/lymphatic spaces should not change the staging. The lateral extent of the lesion is no longer considered. |
| cT1b1 | IB1 | Invasive carcinoma 5 mm depth of stromal invasion and 2 cm in greatest dimension |
| cT1b2 | IB2 | Invasive carcinoma 2 cm and 4 cm in greatest dimension |
| cT1b3 | IB3 | Invasive carcinoma 4 cm in greatest dimension |
| cT2 | II | Cervical carcinoma invades beyond the cervix, but has not extended onto the lower third of the vagina or to the pelvic wall |
| cT2a | IIA | Involvement limited to the upper two-thirds of the vagina without parametrial invasion |
| cT2a1 | IIA1 | Invasive carcinoma 4 cm in greatest dimension |
| cT2a2 | IIA2 | Invasive carcinoma 4 cm in greatest dimension |
| cT2b | IIB | With parametrial invasion but not up to the pelvic wall |
| cT3 | III | Carcinoma involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or non-functioning kidney The pelvic wall is defined as the muscle, fascia, neurovascular structures, and skeletal portions of the bony pelvis. Cases with no cancer-free space between the tumor and pelvic wall by rectal examination are FIGO III. |
| cT3a | IIIA | Carcinoma involves lower third of the vagina, with no extension to the pelvic wall |
| cT3b | IIIB | Extension to the pelvic wall and/or hydronephrosis or non-functioning kidney (unless known to be due to another cause) |
| cT4 | IVA | Carcinoma has involved (biopsy proven) the mucosa of the bladder or rectum, or has spread to adjacent organs. (Bullous edema, as such, does not permit a case to be allotted to stage IVA) |
| pT Category | FIGO Stage | pT Criteria |
|---|---|---|
| pTX | N/A | Primary tumor cannot be assessed |
| pT0 | N/A | No evidence of primary tumor |
| pT1 | I | Carcinoma is strictly confined to the cervix (extension to corpus should be disregarded) |
| pT1a | IA | Invasive carcinoma that can be diagnosed only by microscopy with maximum depth of invasion 5 mm |
| pT1a1 | IA1 | Measured stromal invasion 3 mm in depth |
| pT1a2 | IA2 | Measured stromal invasion 3 mm and 5 mm in depth |
| pT1b | IB | Invasive carcinoma with measured deepest invasion 5 mm (greater than stage IA); lesion limited to the cervix uteri with size measured by maximum tumor diameter The involvement of vascular/lymphatic spaces should not change the staging. The lateral extent of the lesion is no longer considered |
| pT1b1 | IB1 | Invasive carcinoma 5 mm depth of stromal invasion and 2 cm in greatest dimension |
| pT1b2 | IB2 | Invasive carcinoma 2 cm and 4 cm in greatest dimension |
| pT1b3 | IB3 | Invasive carcinoma 4 cm in greatest dimension |
| pT2 | II | Cervical carcinoma invades beyond the cervix, but has not extended onto the lower third of the vagina or to the pelvic wall |
| pT2a | IIA | Involvement limited to the upper two-thirds of the vagina without parametrial invasion |
| pT2a1 | IIA1 | Invasive carcinoma 4 cm in greatest dimension |
| pT2a2 | IIA2 | Invasive carcinoma 4 cm in greatest dimension |
| pT2b | IIB | With parametrial invasion but not up to the pelvic wall |
| pT3 | III | Carcinoma involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or non-functioning kidney The pelvic wall is defined as the muscle, fascia, neurovascular structures, and skeletal portions of the bony pelvis. Cases with no cancer-free space between the tumor and pelvic wall by rectal examination are FIGO III. |
| pT3a | IIIA | Carcinoma involves lower third of the vagina, with no extension to the pelvic wall |
| pT3b | IIIB | Extension to the pelvic wall and/or hydronephrosis or non-functioning kidney (unless known to be due to another cause) |
| pT4 | IVA | Carcinoma has involved (biopsy proven) the mucosa of the bladder or rectum, or has spread to adjacent organs. (Bullous edema, as such, does not permit a case to be allotted to stage IVA) |
| cTX | N/A | Primary tumor cannot be assessed |
| cT0 | N/A | No evidence of primary tumor |
| cT1 | I | Cervical carcinoma confined to the uterus (extension to corpus should be disregarded) |
| cT1a | IA | Invasive carcinoma that can be diagnosed only by microscopy with maximum depth of invasion 5 mm |
| cT1a1 | IA1 | Measured stromal invasion 3 mm in depth |
| cT1a2 | IA2 | Measured stromal invasion 3 mm and 5 mm in depth |
| cT1b | IB | Invasive carcinoma with measured deepest invasion 5 mm (greater than stage IA); lesion limited to the cervix uteri with size measured by maximum tumor diameter The involvement of vascular/lymphatic spaces should not change the staging. The lateral extent of the lesion is no longer considered. |
| cT1b1 | IB1 | Invasive carcinoma 5 mm depth of stromal invasion and 2 cm in greatest dimension |
| cT1b2 | IB2 | Invasive carcinoma 2 cm and 4 cm in greatest dimension |
| cT1b3 | IB3 | Invasive carcinoma 4 cm in greatest dimension |
| cT2 | II | Cervical carcinoma invades beyond the cervix, but has not extended onto the lower third of the vagina or to the pelvic wall |
| cT2a | IIA | Involvement limited to the upper two-thirds of the vagina without parametrial invasion |
| cT2a1 | IIA1 | Invasive carcinoma 4 cm in greatest dimension |
| cT2a2 | IIA2 | Invasive carcinoma 4 cm in greatest dimension |
| cT2b | IIB | With parametrial invasion but not up to the pelvic wall |
| cT3 | III | Carcinoma involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or non-functioning kidney The pelvic wall is defined as the muscle, fascia, neurovascular structures, and skeletal portions of the bony pelvis. Cases with no cancer-free space between the tumor and pelvic wall by rectal examination are FIGO III. |
| cT3a | IIIA | Carcinoma involves lower third of the vagina, with no extension to the pelvic wall |
| cT3b | IIIB | Extension to the pelvic wall and/or hydronephrosis or non-functioning kidney (unless known to be due to another cause) |
| cT4 | IVA | Carcinoma has involved (biopsy proven) the mucosa of the bladder or rectum, or has spread to adjacent organs. (Bullous edema, as such, does not permit a case to be allotted to stage IVA) |
| ycT Category | FIGO Stage | ycT Criteria |
|---|---|---|
| ycTX | N/A | Primary tumor cannot be assessed |
| ycT0 | N/A | No evidence of primary tumor |
| ycT1 | I | Carcinoma is strictly confined to the cervix (extension to corpus should be disregarded) |
| ycT1a | IA | Invasive carcinomathat can be diagnosed only by microscopy with maximum depth of invasion 5 mm |
| ycT1a1 | IA1 | Measured stromal invasion 3 mm in depth |
| ycT1a2 | IA2 | Measured stromal invasion 3 mm and 5 mm in depth |
| ycT1b | IB | Invasive carcinoma with measured deepest invasion 5 mm (greater than stage IA); lesion limited to the cervix uteri with size measured by maximum tumor diameter The involvement of vascular/lymphatic spaces should not change the staging. The lateral extent of the lesion is no longer considered. |
| ycT1b1 | IB1 | Invasive carcinoma 5 mm depth of stromal invasion and 2 cm in greatest dimension |
| ycT1b2 | IB2 | Invasive carcinoma 2 cm and 4 cm in greatest dimension |
| ycT1b3 | IB3 | Invasive carcinoma 4 cm in greatest dimension |
| ycT2 | II | Cervical carcinoma invades beyond the cervix, but has not extended onto the lower third of the vagina or to the pelvic wall |
| ycT2a | IIA | Involvement limited to the upper two-thirds of the vagina without parametrial invasion |
| ycT2a1 | IIA1 | Invasive carcinoma 4 cm in greatest dimension |
| ycT2a2 | IIA2 | Invasive carcinoma 4 cm in greatest dimension |
| ycT2b | IIB | With parametrial invasion but not up to the pelvic wall |
| ycT3 | III | Carcinoma involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or non-functioning kidney The pelvic wall is defined as the muscle, fascia, neurovascular structures, and skeletal portions of the bony pelvis. Cases with no cancer-free space between the tumor and pelvic wall by rectal examination are FIGO III. |
| ycT3a | IIIA | Carcinoma involves lower third of the vagina, with no extension to the pelvic wall |
| ycT3b | IIIB | Extension to the pelvic wall and/or hydronephrosis or non-functioning kidney (unless known to be due to another cause) |
| ycT4 | IVA | Carcinoma has involved (biopsy proven) the mucosa of the bladder or rectum, or has spread to adjacent organs. (Bullous edema, as such, does not permit a case to be allotted to stage IVA) |
| ypT Category | FIGO Stage | ypT Criteria |
|---|---|---|
| ypTX | N/A | Primary tumor cannot be assessed |
| ypT0 | N/A | No evidence of primary tumor |
| ypT1 | I | Carcinoma is strictly confined to the cervix (extension to corpus should be disregarded) |
| ypT1a | IA | Invasive carcinoma that can be diagnosed only by microscopy with maximum depth of invasion 5 mm |
| ypT1a1 | IA1 | Measured stromal invasion 3 mm in depth |
| ypT1a2 | IA2 | Measured stromal invasion 3 mm and 5 mm in depth |
| ypT1b | IB | Invasive carcinoma with measured deepest invasion 5 mm (greater than stage IA); lesion limited to the cervix uteri with size measured by maximum tumor diameter The involvement of vascular/lymphatic spaces should not change the staging. The lateral extent of the lesion is no longer considered. |
| ypT1b1 | IB1 | Invasive carcinoma 5 ›mm depth of stromal invasion and 2 cm in greatest dimension |
| ypT1b2 | IB2 | Invasive carcinoma 2 cm and 4 cm in greatest dimension |
| ypT1b3 | IB3 | Invasive carcinoma 4 cm in greatest dimension |
| ypT2 | II | Cervical carcinoma invades beyond the cervix, but has not extended onto the lower third of the vagina or to the pelvic wall |
| ypT2a | IIA | Involvement limited to the upper two-thirds of the vagina without parametrial invasion |
| ypT2a1 | IIA1 | Invasive carcinoma 4 cm in greatest dimension |
| ypT2a2 | IIA2 | Invasive carcinoma 4 cm in greatest dimension |
| ypT2b | IIB | With parametrial invasion but not up to the pelvic wall |
| ypT3 | III | Carcinoma involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or non-functioning kidney The pelvic wall is defined as the muscle, fascia, neurovascular structures, and skeletal portions of the bony pelvis. Cases with no cancer-free space between the tumor and pelvic wall by rectal examination are FIGO III. |
| ypT3a | IIIA | Carcinoma involves lower third of the vagina, with no extension to the pelvic wall |
| ypT3b | IIIB | Extension to the pelvic wall and/or hydronephrosis or non-functioning kidney (unless known to be due to another cause) |
| ypT4 | IVA | Carcinoma has involved (biopsy proven) the mucosa of the bladder or rectum, or has spread to adjacent organs. (Bullous edema, as such, does not permit a case to be allotted to stage IVA) |
| N Category | FIGO Stage | N Criteria |
|---|---|---|
| NX | N/A | Regional lymph nodes cannot be assessed |
| N0 | N/A | No regional lymph node metastasis |
| N0(i+) | N/A | Isolated tumor cells in regional lymph node(s) 0.2 mm, or single cells or clusters of cells 200 cells in a single lymph node cross section |
| N1 | IIIC1 | Regional lymph node metastasis to pelvic lymph nodes only |
| N1mi | IIIC1 | Regional lymph node metastasis ( 0.2 mm but 2.0 mm in diameter) to pelvic lymph nodes |
| N1a | IIIC1 | Regional lymph node metastasis ( 2.0 mm in diameter) to pelvic lymph nodes |
| N2 | IIIC2 | Regional lymph node metastasis to paraaortic lymph nodes, with or without positive pelvic lymph nodes |
| N2mi | IIIC2 | Regional lymph node metastasis ( 0.2 mm but 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes |
| N2a | IIIC2 | Regional lymph node metastasis ( 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes |
Suffix (f) is added to the N category when metastasis is identified only by FNA or core biopsy. Suffix (sn) is added to the N category when metastasis is identified only by sentinel lymph node biopsy.
| cN Category | FIGO Stage | cN Criteria |
|---|---|---|
| cNX | N/A | Regional lymph nodes cannot be assessed |
| cN0 | N/A | No regional lymph node metastasis |
| cN0(i+) | N/A | Isolated tumor cells in regional lymph node(s) 0.2 mm, or single cells or clusters of cells 200 cells in a single lymph node cross section |
| cN1 | IIIC1 | Regional lymph node metastasis to pelvic lymph nodes only |
| cN1mi | IIIC1 | Regional lymph node metastasis ( 0.2 mm but 2.0 mm in diameter) to pelvic lymph nodes |
| cN1a | IIIC1 | Regional lymph node metastasis ( 2.0 mm in diameter) to pelvic lymph nodes |
| cN2 | IIIC2 | Regional lymph node metastasis to paraaortic lymph nodes, with or without positive pelvic lymph nodes |
| cN2mi | IIIC2 | Regional lymph node metastasis ( 0.2 mm but 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes |
| cN2a | IIIC2 | Regional lymph node metastasis ( 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes |
Suffix (f) is added to the N category when metastasis is identified only by FNA or core biopsy. Suffix (sn) is added to the N category when metastasis is identified only by sentinel lymph node biopsy.
| pN Category | FIGO Stage | pN Criteria |
|---|---|---|
| pNX | N/A | Regional lymph nodes cannot be assessed |
| pN0 | N/A | No regional lymph node metastasis |
| pN0(i+) | N/A | Isolated tumor cells in regional lymph node(s) 0.2 mm, or single cells or clusters of cells 200 cells in a single lymph node cross section |
| pN1 | IIIC1 | Regional lymph node metastasis to pelvic lymph nodes only |
| pN1mi | IIIC1 | Regional lymph node metastasis ( 0.2 mm but 2.0 mm in diameter) to pelvic lymph nodes |
| pN1a | IIIC1 | Regional lymph node metastasis ( 2.0 mm in diameter) to pelvic lymph nodes |
| pN2 | IIIC2 | Regional lymph node metastasis to paraaortic lymph nodes, with or without positive pelvic lymph nodes |
| pN2mi | IIIC2 | Regional lymph node metastasis ( 0.2 mm but 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes |
| pN2a | IIIC2 | Regional lymph node metastasis ( 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes |
| cNX | N/A | Regional lymph nodes cannot be assessed |
| cN0 | N/A | No regional lymph node metastasis |
| cN0(i+) | N/A | Isolated tumor cells in regional lymph node(s) than 0.2 mm, or single cells or clusters of cells 200 cells in a single lymph node cross section |
| cN1 | IIIC1 | Regional lymph node metastasis to pelvic lymph nodes only |
| cN1mi | IIIC1 | Regional lymph node metastasis ( 0.2 mm but 2.0 mm in diameter) to pelvic lymph nodes |
| cN1a | IIIC1 | Regional lymph node metastasis ( 2.0 mm in diameter) to pelvic lymph nodes |
| cN2 | IIIC2 | Regional lymph node metastasis to paraaortic lymph nodes, with or without positive pelvic lymph nodes |
| cN2mi | IIIC2 | Regional lymph node metastasis ( 0.2 mm but 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes |
| cN2a | IIIC2 | Regional lymph node metastasis ( 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes |
Suffix (f) is added to the N category when metastasis is identified only by FNA or core biopsy. Suffix (sn) is added to the N category when metastasis is identified only by sentinel lymph node biopsy.
| ycN Category | FIGO Stage | ycN Criteria |
|---|---|---|
| ycNX | N/A | Regional lymph nodes cannot be assessed |
| ycN0 | N/A | No regional lymph node metastasis |
| ycN0(i+) | N/A | Isolated tumor cells in regional lymph node(s) 0.2 mm, or single cells or clusters of cells 200 cells in a single lymph node cross section |
| ycN1 | IIIC1 | Regional lymph node metastasis to pelvic lymph nodes only |
| ycN1mi | IIIC1 | Regional lymph node metastasis ( 0.2 mm but 2.0 mm in diameter) to pelvic lymph nodes |
| ycN1a | IIIC1 | Regional lymph node metastasis ( 2.0 mm in diameter) to pelvic lymph nodes |
| ycN2 | IIIC2 | Regional lymph node metastasis to paraaortic lymph nodes, with or without positive pelvic lymph nodes |
| ycN2mi | IIIC2 | Regional lymph node metastasis ( 0.2 mm but 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes |
| ycN2a | IIIC2 | Regional lymph node metastasis ( 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes |
Suffix (f) is added to the N category when metastasis is identified only by FNA or core biopsy. Suffix (sn) is added to the N category when metastasis is identified only by sentinel lymph node biopsy.
| ypN Category | FIGO Stage | ypN Criteria |
|---|---|---|
| ypNX | N/A | Regional lymph nodes cannot be assessed |
| ypN0 | N/A | No regional lymph node metastasis |
| ypN0(i+) | N/A | Isolated tumor cells in regional lymph node(s) 0.2 mm, or single cells or clusters of cells 200 cells in a single lymph node cross section |
| ypN1 | IIIC1 | Regional lymph node metastasis to pelvic lymph nodes only |
| ypN1mi | IIIC1 | Regional lymph node metastasis ( 0.2 mm but 2.0 mm in diameter) to pelvic lymph nodes |
| ypN1a | IIIC1 | Regional lymph node metastasis ( 2.0 mm in diameter) to pelvic lymph nodes |
| ypN2 | IIIC2 | Regional lymph node metastasis to paraaortic lymph nodes, with or without positive pelvic lymph nodes |
| ypN2mi | IIIC2 | Regional lymph node metastasis ( 0.2 mm but 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes |
| ypN2a | IIIC2 | Regional lymph node metastasis ( 2.0 mm in diameter) to para-aortic lymph nodes, with or without positive pelvic lymph nodes |
Suffix (f) is added to the N category when metastasis is identified only by FNA or core biopsy. Suffix (sn) is added to the N category when metastasis is identified only by sentinel lymph node biopsy.
| M Category | FIGO Stage | M Criteria |
|---|---|---|
| M0 | N/A | No distant metastasis |
| M1 | IVB | Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone) (excludes metastasis to pelvic or para-aortic lymph nodes, or vagina) |
| M1 | IVB | Microscopic evidence of distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone) (excludes metastasis to pelvic or para-aortic lymph nodes, or vagina) |
| cM Category | FIGO Stage | cM Criteria |
|---|---|---|
| cM0 | N/A | No distant metastasis |
| cM1 | IVB | Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone) (excludes metastasis to pelvic or para-aortic lymph nodes, or vagina) |
| pM1 | IVB | Microscopic evidence of distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone) (excludes metastasis to pelvic or para-aortic lymph nodes, or vagina) |
| pM Category | FIGO Stage | pM Criteria |
|---|---|---|
| cM0 | N/A | No distant metastasis |
| cM1 | IVB | Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone) (excludes metastasis to pelvic or para-aortic lymph nodes, or vagina) |
| pM1 | IVB | Microscopic evidence of distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone) (excludes metastasis to pelvic or para-aortic lymph nodes, or vagina) |
| ycM Category | FIGO Stage | ycM Criteria |
|---|---|---|
| cM0 | N/A | No distant metastasis |
| cM1 | IVB | Distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone) (excludes metastasis to pelvic or para-aortic lymph nodes, or vagina) |
| pM1 | IVB | Microscopic evidence of distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone) (excludes metastasis to pelvic or para-aortic lymph nodes, or vagina) |
| ypM Category | FIGO Stage | ypM Criteria |
|---|---|---|
| cM0 | N/A | No distant metastasis |
| cM1 | IVB | Distant metastasis(includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone(excludes metastasis to pelvic or para-aortic lymph nodes, or vagina) |
| pM1 | IVB | Microscopic evidence of distant metastasis (includes metastasis to inguinal lymph nodes, intraperitoneal disease, lung, liver, or bone) (excludes metastasis to pelvic or para-aortic lymph nodes, or vagina) |